Systemic Immune-Inflammatory Biomarkers in Epithelial Ovarian Cancer: Subgroup-Dependent Prognostic Performance and Integrated Risk Stratification
E Sun Paik, Young Eun Chung, Seoyoung Youn, Seongyun Lim, Jun-Hyeong Seo, Chel Hun Choi, Tae-Joong Kim, Jeong-Won Lee, Yoo-Young Lee · 2026
Read Systemic Immune-Inflammatory Biomarkers in Epithelial Ovarian Cancer: Subgroup-Dependent Prognostic Performance and Integrated Risk Stratification by E Sun Paik, Young Eun Chung, Seoyoung Youn, Seongyun Lim, Jun-Hyeong Seo, Chel Hun Choi, Tae-Joong Kim, Jeong-Won Lee, Yoo-Young Lee (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13566507.txt.
Description
Sun Paik and co-authors published this study in 2026. It grades inflammation blood scores as outlook markers in ovarian cancer. Three ratios built from blood cell counts were tracked around surgery in 373 patients. Changes from before to the day after surgery were tested across ten patient subgroups. Single markers sorted outcomes only modestly. Which marker led changed with the subgroup, and none clearly beat the others.
The team then built a combined risk score, adding stage and leftover tumor to the blood data. That score spread six-fold between its lowest and highest risk bands. It stayed tied to survival after adjustment. Still, it did not clearly beat stage and leftover tumor alone. A gene check found one vessel gene higher in a rare subtype. The authors call for prospective tests before clinical use.
Catalog record
| CREATOR | E Sun Paik, Young Eun Chung, Seoyoung Youn, Seongyun Lim, Jun-Hyeong Seo, Chel Hun Choi, Tae-Joong Kim, Jeong-Won Lee, Yoo-Young Lee |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |